Insmed: UBS Maintains Buy Rating, Raises PT to $223 from $194

Friday, Oct 31, 2025 12:02 pm ET1min read
INSM--

Insmed: UBS Maintains Buy Rating, Raises PT to $223 from $194

Insmed: UBS Maintains Buy Rating, Raises PT to $223 from $194

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet